Virtual ward aims to keep heart failure patients home

NCT ID NCT06620653

Recruiting now Disease control Sponsor: National University of Ireland, Galway, Ireland Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 2 times

Summary

This study tests whether a virtual ward—using a tablet, scale, and blood pressure monitor at home—can reduce hospital readmissions for heart failure patients. 346 adults who were recently hospitalized for heart failure will either receive the virtual ward or standard care. Researchers will track hospitalizations, deaths, costs, and quality of life over 3 to 12 months.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: telemonitoring (tablet, weight scale, blood pressure monitor) plus symptom reporting
What this could lead to: If it works, this could offer a way to manage heart failure at home, reducing hospital stays and improving quality of life.
What could go wrong: This is an early-stage study without blinding, so results may be less reliable. The virtual ward may not reduce hospitalizations or could be too costly for widespread use.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEART FAILURE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

heart failure

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HEART FAILURE

Contacts and locations

Locations

Portiuncula University Hospital
RECRUITING

Ballinasloe, Galway, H53 T971, Ireland

More trials for these conditions

Other studies related to the condition(s) this trial covers.